Evidence map›Paper›PMID 35278213›Full record

ArticleJournal of the American Geriatrics Society2022

Out-of-pocket costs attributable to dementia: A longitudinal analysis.

Melissa Oney, Lindsay White, Norma B Coe

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
10.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Housing Assistance and Health Care Access Among Older Adults with Alzheimer's Disease and Related Dementias: Evidence from Multisource Linked Survey-Administrative Data.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2026
    Article
  2. Estimating the magnitude and scope of disability-related direct costs: a systematised review.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2025
    Article
  8. Review
  9. Medicare expenditures among spouses of persons with dementia.Journal of the American Geriatrics Society · 2024
    Article
  10. 2024 Alzheimer's disease facts and figures.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Melissa OneyPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lindsay WhiteCenter for Health Care Quality and Outcomes, RTI International, Seattle, Washington, USA.
Norma B CoePerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-1228-0938
University of Pennsylvania · USRTI International · US

Funding

Current and Future Costs of Alzheimer's and Dementia CareR01AG049815 · NIA · UNIVERSITY OF WASHINGTON · PI COE, NORMA B · 2015 to 2018
$2.1M
NIA NIH HHS R01 AG049815US Department of Health & Human Services
6 · The paper itself

Abstract

backgroundAlzheimer's disease and related dementias (ADRD) affect 5.7 million Americans, and are expensive despite the lack of a cure or even treatments effective in managing the disease. The literature thus far has tended to focus on the costs to Medicare, even though one of the main characteristics of ADRD (the loss of independence and ability to care for oneself) incurs costs not covered by Medicare.

methodsIn this paper, we use survey data for 2002-2016 from the Health and Retirement Study to estimate the out-of-pocket costs of ADRD for the patient and their family through the first 8 years after the onset of symptoms, as defined by a standardized 27-point scale of cognitive ability. A two-part model developed by Basu and Manning (2010) allows us to separate the costs attributable to ADRD into two components, one driven by differences in longevity and one driven by differences in utilization.

resultsWe identified a cohort of 3619 incident dementia cases, 38.9% were male, and 66.9% were non-Hispanic White. Dementia onset was 77.7 years of age, on average. OOP costs attributable to dementia are $8751 over the first 8 years after the onset. These incremental costs are driven by nursing home expenditures, which are largely uninsured in the US. OOP spending is highest for whites and women.

conclusionThe financial burden of ADRD is significant, and largely attributable to the lack of wide-spread long-term care insurance.

Indexed as

Alzheimer DiseaseHealth ExpendituresAgedEthnicityFemaleHumansMaleMedicareNursing HomesUnited Statesdementialong-term services and supportsout-of-pocket costs

Identifiers

PMID35278213
PMCPMC9106861
OpenAlexW4221023005

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.